Venture Capital
Inside Formation Bio's $600 Million Hub-and-Spoke Drug Development Fund
Formation Bio has launched a $600 million fund using a novel "hub-and-spoke" model to acquire and advance drug programs through clinical development. This structure separates financial risk per asset from a centralized operating platform, aiming to overcome clinical development bottlenecks.
Marco Giuliani·November 5, 2026
